SCHEMBL271881

SCHEMBL271881

O=S(=O)(O)c1ccc(C2=C3C=CC(=N3)C(c3ccc(S(=O)(=O)O)cc3)=C3C=CC(=N3)C(c3ccc(S(=O)(=O)O)cc3)=C3C=CC(=N3)C(c3ccccc3)=C3C=CC2=N3)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ POLB P06746 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.40
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ PTGS2 P35354 4/20 0.36
▸ ENPP2 Q13822 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PHGDH O43175 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP7 P09237 1/20 0.36
▸ MMP14 P50281 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ NT5E P21589 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL267948 0.94 LMNA (0.41) TSHRSMN1; SMN2POLBCYP2D6HDAC6
SCHEMBL17768421 0.92 LMNA (0.39) TSHRSMN1; SMN2POLBCYP2D6HDAC6
SCHEMBL15004685 0.92 LMNA (0.39) TSHRSMN1; SMN2POLBCYP2D6HDAC6
Water SCHEMBL9870236 0.92 LMNA (0.39) TSHRSMN1; SMN2POLBCYP2D6HDAC6
SCHEMBL20379960 0.92 LMNA (0.39) TSHRSMN1; SMN2POLBCYP2D6HDAC6
Water SCHEMBL23522818 0.92 LMNA (0.39) TSHRSMN1; SMN2POLBCYP2D6HDAC6
Water SCHEMBL14977045 0.90 LMNA (0.38) TSHRSMN1; SMN2POLBCYP2D6HDAC6
SCHEMBL7258220 0.88 LMNA (0.53) TSHRSMN1; SMN2POLBCYP2D6CA12
SCHEMBL10676586 0.87 CA12 (0.44) TSHRCA12CA1CA2CA9
SCHEMBL8167637 0.80 ENPP2 (0.32) TSHRENPP2LMNAALDH1A1NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133474-B2 Porphyrin chelate compound that may be complexed with zinc, manganese, magnesium, iron or aluminum; capable of insertion into cell; zinc, calcium, mercury, cadmium, and lead analytes; determining shift in signal; medical diagnosis MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-03-13 — — US disclosed
US-20080138292-A1 Sensors for fluorescence and magnetic resonance imaging MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2008-06-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138292-A1 Sensors for fluorescence and magnetic resonance imaging CA2, SLC30A6, SLC39A3 TSHR 4006/4885SMN1; SMN2 876/4885POLB 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback